Status:
TERMINATED
COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19
Lead Sponsor:
CMC Ambroise Paré
Conditions:
COVID-19
SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Covid-19 pandemic requires a reliable diagnosis of patients in order to take care of them in the best conditions and in the appropriate services. Moreover, the current diagnostic reference is reve...
Detailed Description
All outpatients and hospitalized patients (intensive care unit, internal medicine service and emergency service) will be proposed to participate to the study after assessment of eligibility criteria b...
Eligibility Criteria
Inclusion
- Patients undergoing nasopharyngeal SARS CoV2 RT-PCR testing
Exclusion
- \< 18 years old
- Having signed a written informed consent form,
- Affiliation to the social security system.
Key Trial Info
Start Date :
January 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2021
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT04703140
Start Date
January 27 2021
End Date
May 4 2021
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Robert Ballanger
Aulnay-sous-Bois, France